Journal of Hepatology
Volume 49, Issue 4 , Pages 608-612 , October 2008

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease

  • Janus P. Ong

      Affiliations

    • Center for Liver Diseases, Inova Fairfax Hospital, 3289 Woodburn Road, Suite 375, Annandale, VA 22003, USA
    • Outcomes Research Program, Inova Health System, Falls Church, VA, USA
    • ,
  • Angela Pitts

      Affiliations

    • RTI International, Research Triangle Park, NC, USA
    • ,
  • Zobair M. Younossi

      Affiliations

    • Center for Liver Diseases, Inova Fairfax Hospital, 3289 Woodburn Road, Suite 375, Annandale, VA 22003, USA
    • Outcomes Research Program, Inova Health System, Falls Church, VA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 703 208 6648; fax: +1 703 208 6655.

Received 21 April 2008 ,Revised 3 June 2008 ,Accepted 10 June 2008.

References 

  1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the united states: impact of ethnicity. Hepatology. 2004;40:1387–1395
  2. Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis. 2007;11:1–16
  3. Adams LA, Lymp JF, St. Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113–121
  4. Analytic and Reporting Guidelines: The third national health and nutrition examination survey, NHANES III (1988–94), 1996.
  5. NHANES III linked mortality file. 2007 September 12. Available from http://www.cdc.gov/nchs/r&d/nchs_datalinkage/nhanes3_data_linkage_mortality_activities.htm#data_file_description.
  6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486–97.
  7. Liou I, Kowdley KV. Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol. 2006;40:S11–S16
  8. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–1419
  9. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–873
  10. Dam-Larsen S, Franzmann M, Andersen IB, Christoffersen P, Jensen LB, Sorensen TI, et al. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut. 2004;53:750–755
  11. Younossi ZM, Gramlich T, Matteoni CA, Boparai N, McCullough AJ. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol. 2004;2:262–265
  12. Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol. 2005;16:421–427
  13. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;191:235–240
  14. Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology. 2003;38:420–427
  15. Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis. 2007;11:191–207
  16. Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the united states in 1999–2002. Am J Gastroenterol. 2006;101:76–82
  17. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the united states. Am J Gastroenterol. 2003;98:960–967
  18. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the united states. Gastroenterology. 2003;124:71–79
  19. Dunn W, Xu R, Wingard D, Rogers C, Angulo P, Younossi Z, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Gastroenterology. 2008;134:A781

☆ The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

PII: S0168-8278(08)00423-6

doi: 10.1016/j.jhep.2008.06.018

Journal of Hepatology
Volume 49, Issue 4 , Pages 608-612 , October 2008

Article Tools

* Image Usage & Resolution